NaturalX Health Ventures has announced the launch of a €100 million (US$105 million) fund aimed at supporting consumer health startups in Europe.

This fund focuses on the intersection of wellness and medicine and seeks to foster innovation in proactive health management in response to market needs.

The fund plans to primarily invest in series A financing rounds, allowing flexibility for late seed and series B rounds.

Initial investments will range from €3 million (US$3.32 million) to €5 million (US$5.53 million), with the possibility of follow-on investments up to €10 million (US$11.05 million) per company.

The venture will operate as both a lead or co-investor, with a focus on European startups while also considering selected investments in North America.

Founded by Marvin Amberg, a German entrepreneur with experience in consumer health startups, naturalX has partnered with Schwabe Group, known for its plant-based pharmaceuticals.